Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.
Clinical trial NCT05922345 · UNKNOWN
Trial details
- NCT number
- NCT05922345
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-08
- Primary completion
- 2025-08-01
- Enrollment
- 518
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.